Antibiotic Resistance in Neonatal Children
Mutalibova NF1 and Guliyeva MZ2
1Azerbaijan State Advanced Training Institute for Doctors, Baku, Azerbaijan
2Liv Bonadea hospital, Baku, Azerbaijan
*Corresponding Author: Guliyeva MZ, Liv Bonadea hospital, Baku, Azerbaijan.
Received:
August 09, 2023; Published: September 08, 2023
Abstract
The problem of neonatal mortality from bacterial infections is exacerbated by the growing resistance to antimicrobials reported throughout the world. In our country, the problem of antimicrobial resistance, especially in children under 5 years old, is one of the most urgent.
Keywords: Antibiotic Resistance; Neonatal Children; Multiresistant Bacteria
References
- Wellcome Trust and UK Government. “Tackling drug-resistant infections globally: final report and recommendations” (The Review on Antimicrobial Resistance) (2016).
- Luyt CE., et al. “Antibiotic stewardship in the intensive care unit”. Critical Care 18 (2014): 480.
- Okomo U., et al. “Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: A systematic review and meta-analysis in line with the STROBE-NI reporting guidelines”. The Lancet Infectious Diseases 19 (2019) :1219-1234.
- Roope LSJ., et al. “The challenge of antimicrobial resistance: what economics can contribute”. Science 364 (2019): eaau4679.
- Johnston KJ., et al. “The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate”. Health Services Research 54 (2019): 782-792.
- Naylor NR., et al. “Estimating the burden of antimicrobial resistance: A systematic literature review”. Antimicrobial Resistance and Infection Control 7 (2018): 58.
- Barrasa-Villar JI., et al. “Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms”. Clinical Infectious Diseases 65 (2017): 644-652.
- Eck A., et al. “Neonatal microbiota development and the effect of early life antibiotics are determined by two distinct settler types”. PLoS ONE 15 (2020): e0228133.
- Tchesnocova VL., et al. “Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women”. Clinical Infectious Diseases 5 (2020): 937-939.
- Le Doare K., et al. “Improving antibiotic prescribing for children in the resource-poor setting”. British Journal of Clinical Pharmacology 79 (2015): 446-455.
- Gasanov AM. “Use of bacterial preparations for pasteurellosis infection. Scientific Bulletin of Lviv National University of Veterinary Medicine and Biotechnology 21 (2019): 114-116.
- Bogomolova NS., et al. “Problem of treatment for pyo-inflammatory complications caused by Acinetobacter”. Anesteziologiya i Reanimatologiya 1 (2014): 26-32.
- Anganova EV., et al. “State of antibiotic resistance of Klebsiella pneumoniae”. Journal of Microbiology 5 (2017): 70-77.
- Petrovskaya TA., et al. “Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa”. Clinical Microbiology and Antimicrobial Chemotherapy2 (2020): 128-136.
- Zerr DM., et al. “Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients. Antimicrob”. Agents and Chemotherapy 60 (2016): 4237-4243.
- Gu D., et al. “A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study”. The Lancet Infectious Diseases 1 (2017): 37-46.
- Heilmann C., et al. “Are coagulase-negative staphylococci virulent?” Clinical Microbiology and Infection 9 (2019): 1071-1080.
Citation
Copyright